Florida Cancer Specialists Press Release
FOR IMMEDIATE RELEASE
Dr. Muhammad Imam & Dr. Yaman Suleiman Join Florida Cancer Specialists
Nation’s Largest Independent Oncology Group Adds Two Physicians to Central Florida Offices
Orlando, FL – August 4, 2016……… Florida Cancer Specialists & Research Institute (FCS), the leading community oncology/hematology practice in the state, is pleased to announce that Muhammed Imam, MD and Yaman Suleiman, MD have joined the practice and will be seeing patients at theOrange Orlando office of Florida Cancer Specialists, located at 2501 N. Orange Avenue, Suites 381 and 389, Orlando, FL and the Winter Park office, located at 2100 Glenwood Drive, Suite 102, Winter Park, FL.
FCS CEO Brad Prechtl said, "Both of these physicians come to us with outstanding credentials. I know they will bring added convenience to our patients in Central Florida and we are delighted to welcome Drs. Imam and Suleiman to the FCS family.”
Dr. William Harwin, Founder and President of FCS, added, “Both of these physicians have completed excellent training at some of the finest medical facilities in the nation. Additionally, Drs. Imam and Suleiman have expressed a keen interest in clinical research, which is such an important focus for our practice. They will be a great addition to our offices in Orange County.”
Muhammad Imam, MD
Dr. Muhammad “Hassan” Imam was born in Santa Barbara, California, but grew up most of his life in Deltona, Florida. He was valedictorian of his high school and graduated Summa Cum Laude from the University of Miami. Dr. Imam joined Florida Cancer Specialists after completinghis Fellowship in Hematology/ Oncology at the University of Texas Southwestern in Dallas, TX. During his Fellowship, he often gave CME presentations on various cancer topics and he also presented at the National T-Cell Lymphoma Forum in San Francisco in 2012. Dr. Imam has been published in several journals, including Leukemia & Lymphoma and the prestigious American Journal of Clinical Oncology. In additional to being a husband and father of two young children, Dr. Imam is a co-founder of Project Downtown, a non-profit organization that serves the homeless and needy populations in over 20 cities nationwide. Project Downtown began several years ago as an informal initiative by a group of students at the University of Miami who were determined to make a difference in the lives of these individuals.
Yaman Suleiman, MD
After completing his Fellowship in Oncology/Hematology at Moffitt Cancer Center, Dr. Yaman Suleiman joined Florida Cancer Specialists’ offices in Central Florida. While in medical school, Dr. Suleiman volunteered totreat patients in underserved areas and participated in several prevention programs; his training included additional sub-internships at Cleveland Clinic Foundation, University of Illinois College of Medicine and a clinical rotation at Duke University School of Medicine. Dr. Suleiman treats patients with a broad range of oncologic and hematologic diseases. He has a special interest in multiple myeloma,colon, lung and breast cancers, as well as a keen interest in translational and clinical research. He participated in severalretrospective and prospective studies and he has been published in such prestigious journals as Biology of Bloodand Marrow Transplantation Journal, Leukemia Research Journal, Cancer Chemotherapy Pharmacology Journal and Cancer Control Journal. He hasalso given numerous presentations and delivered abstracts at bothregional and national Oncology/Hematology conferences.Fluent in two languages, Dr. Suleiman enjoys swimming, soccer and traveling in his personal time, as well as spending time with his wife and two children.
Dr. Lee Zehngebot , one of the founders of the practices in Orlando and Winter Park, said, “The six physicians in our local group have been together for over a decade and, as our practice continues to grow, we recognized the need to add new physicians to better serve our patients. We believe the addition of Drs. Imam and Suleiman will greatly benefit our patients and we are delighted to welcome them to our practice.”
Florida Cancer Specialists & Research Institute offers a full range of oncology and hematology services, including clinical research and the use of evidence-based medicine and proactive patient support services. FCS is a strategic site of the Sarah Cannon Research Institute, one of the largest community-based clinical trial organizations in the United States.
About Florida Cancer Specialists & Research Institute: (FLCancer.com)
Founded in 1984, Florida Cancer Specialists & Research Institute (FCS) is the largest independent medical oncology/hematology practice in the United States. With over 180 physicians, 150 nurse practitioners and physician assistants and over 90 locations in our network, we are committed to providing world-class cancer care in community-based settings close to home.
Recognized by the American Society of Clinical Oncology (ASCO) with a national Clinical Trials Participation Award, FCS offers patients access to more clinical trials than any private oncology practice in Florida. 70% of new cancer drugs approved in 2015 for use in the U.S. were studied in clinical trials conducted with FCS participation*. Our physicians are consistently ranked nationally as Top Doctors by U.S. News & World Report. Trained in such prestigious medical schools and research institutes as Duke, Stanford, Harvard, Emory, M.D. Anderson, and Memorial Sloan-Kettering, the physicians of Florida Cancer Specialists provide leadership and consultation in the state's leading hospitals.
FCS serves patients on the Gulf Coast from Naples to the greater Tampa Bay area, north as far as Tallahassee, in Orlando and surrounding Central Florida communities, and on the East Coast in Daytona/Palm Coast, Vero Beach/Sebastian and in Palm Beach County.
Florida Cancer Specialists has built a national reputation for excellence that is reflected in exceptional and compassionate patient care, driven by innovative clinical research and cutting-edge technologies that help advance targeted treatments and genetically-based immunotherapies, and embodied by our outstanding team of highly-trained and dedicated physicians, clinicians and staff.
* Prior to approval
For More Information, Contact:
Florida Cancer Specialists & Research Institute
Shelly Glenn, Chief Marketing & Sales Officer -
Chris Wilkerson -
813.281.0088 ext. 315
Ganick Communications, Inc.
Elaine Ganick -